Xencor (NASDAQ:XNCR) Price Target Cut to $50.00 by Analysts at Mizuho

Xencor (NASDAQ:XNCR – Free Report) had its price target trimmed by Mizuho from $59.00 to $50.00 in a research report report published on Monday, Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. Other equities research analysts have also recently issued research reports about the company. StockNews.com raised Xencor from […]

Related Keywords

Canada ,China ,Bassili Dahiyat , ,Royal Bank ,China Universal Asset Management Co ,Mirae Asset Global Investments Co ,Xencor Inc ,Exchange Traded Concepts ,Free Report ,Moderate Buy ,Trading Down ,Get Free Report ,Asset Global Investments ,Universal Asset Management ,Traded Concepts ,Xencor Daily ,Xencor ,Nasdaq Xncr ,Xncr ,Medical ,Lower Price Target ,Mizuho ,